Honeywell offers Â£1.2bn for Novar
UK mini-conglomerate Novar has unveiled an Â£1.2bn ($2.3bn) bid from Honeywell of the US, a month on from rejecting another offer from Melrose.
- Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of improved overall survival.